Sanara Medtech Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.0% | 19.0% | 10.8% | 11.3% | 14.9% | 14.0% | 10.8% | 7.0% | 7.4% | 47.6% | 11.6% | 11.1% | 9.8% | 10.4% | 9.4% | 11.8% | 10.4% | 10.2% | 9.5% | 8.5% | 8.9% | 11.1% | 10.3% | 9.9% | 17.1% | 15.5% | 13.7% | 13.9% | 10.9% | 10.1% | 10.2% | 10.0% | 9.2% | 8.6% | 10.8% | 7.5% | 9.4% | 9.2% | 9.0% | 7.0% | 8.7% | |
| 85.0% | 81.0% | 89.2% | 88.7% | 85.1% | 86.0% | 89.2% | 93.0% | 92.6% | 52.4% | 88.4% | 88.9% | 90.2% | 89.6% | 90.6% | 88.2% | 89.6% | 89.8% | 90.5% | 91.5% | 91.1% | 88.9% | 89.7% | 90.1% | 82.9% | 84.5% | 86.3% | 86.1% | 89.1% | 89.9% | 89.8% | 90.0% | 90.8% | 91.4% | 89.2% | 92.5% | 90.6% | 90.8% | 91.0% | 93.0% | 91.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1% | 1.4% | 0.3% | 0.6% | 2.4% | 1.7% | 0.6% | 4.3% | 2.6% | 11.0% | 8.1% | 6.8% | 8.5% | 7.5% | 6.2% | 3.7% | 5.1% | 4.9% | 6.3% | 9.2% | 4.8% | 4.9% | 3.9% | 7.4% | 2.7% | 4.1% | 4.5% | |
| 68.4% | 162.0% | 84.1% | 78.9% | 84.1% | 86.9% | 84.3% | 90.5% | 99.7% | 992.9% | 94.5% | 98.9% | 114.0% | 131.8% | 125.4% | 122.1% | 118.0% | 284.0% | 271.5% | 104.5% | 118.8% | 130.3% | 120.0% | 107.8% | 92.5% | 92.1% | 83.6% | 87.7% | 86.6% | 92.3% | 87.4% | 94.0% | 87.6% | 85.2% | 91.5% | 83.4% | 75.5% | 72.9% | 78.7% | 80.3% | 76.9% | |
| 69.7% | 65.2% | 85.5% | 80.5% | 87.0% | 86.3% | 85.4% | 91.5% | 101.0% | 1,036.0% | 94.7% | 99.6% | 115.5% | 133.3% | 141.6% | 124.6% | 119.9% | 107.6% | 112.2% | 107.8% | 122.9% | 137.4% | 125.2% | 125.1% | 107.7% | 104.9% | 94.1% | 98.0% | 94.7% | 91.2% | 98.1% | 104.3% | 99.7% | 92.9% | 85.7% | 92.6% | 79.3% | 80.3% | 81.4% | 86.6% | 82.0% | |
| 15.3% | 15.9% | 3.6% | 8.2% | -1.9% | -1.6% | 3.4% | 1.4% | -8.4% | -983.6% | -6.3% | -10.7% | -27.4% | -43.6% | -51.0% | -36.4% | -30.3% | -17.8% | -21.6% | -16.3% | -31.8% | -48.5% | -35.5% | -35.0% | -24.8% | -20.4% | -7.8% | -11.8% | -5.7% | -1.3% | -8.3% | -14.3% | -8.9% | -1.4% | 3.5% | -0.1% | 11.2% | 10.5% | 9.5% | 6.3% | 9.4% | |
| 3.0% | 2.4% | 2.8% | 3.5% | 1.3% | 0.7% | 3.1% | 0.1% | 0.4% | 40.0% | 0.2% | 1.0% | 1.6% | 0.7% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 2.9% | 3.3% | 2.0% | 4.9% | 0.7% | 0.8% | 0.7% | 0.0% | 0.0% | 1.2% | 1.6% | 1.4% | 3.2% | 4.3% | 4.9% | 5.6% | 6.9% | 6.9% | 6.7% | 6.5% | 6.4% | 6.6% | |
| 12.9% | 13.5% | 3.3% | 5.4% | -3.1% | 14.6% | 0.3% | 1.4% | -9.6% | -1,024.3% | -6.5% | -11.7% | -29.0% | -44.1% | -52.2% | -38.1% | -28.1% | -5.6% | -23.6% | -19.2% | -35.2% | -50.6% | -40.4% | -35.0% | -24.8% | -27.2% | -7.8% | -11.8% | -6.8% | -1.5% | -9.7% | -17.5% | -13.3% | -6.5% | -2.6% | -7.8% | 3.2% | -4.0% | 1.4% | -1.5% | -0.3% | |
| -0.6% | – | 0.0% | -0.8% | 0.0% | -15.6% | 0.5% | 0.1% | 1.2% | – | 0.2% | 0.0% | 1.8% | 1.1% | 0.7% | -0.1% | -1.4% | -12.7% | 0.0% | -0.5% | -0.5% | -0.1% | -0.3% | -42.8% | -13.1% | 49.3% | 1.9% | -0.2% | -0.2% | -2.0% | -0.2% | -0.1% | – | 0.1% | – | – | – | – | – | – | – | |
| 12.9% | 13.5% | 3.3% | 5.4% | -3.1% | 14.6% | 0.3% | 1.4% | -9.6% | -1,024.3% | -6.5% | -11.6% | -28.8% | -43.6% | -52.1% | -37.9% | -26.6% | -5.1% | -23.6% | -18.7% | -34.7% | -50.4% | -40.1% | 8.0% | -11.3% | -26.8% | -7.6% | -11.6% | -6.6% | -1.3% | -9.5% | -17.4% | -13.2% | -5.8% | -15.0% | -7.8% | -115.5% | -5.8% | 1.7% | -1.6% | -29.2% | |
| 16.4% | 16.7% | 4.9% | 9.6% | 0.8% | 15.2% | 4.4% | 2.3% | -7.8% | -940.4% | -6.1% | -10.0% | -25.8% | -41.9% | -49.4% | -33.9% | -26.1% | -16.1% | -21.2% | -17.6% | -31.7% | -47.7% | -37.8% | -28.8% | -17.7% | -13.1% | -5.7% | -9.0% | 0.6% | -6.1% | -2.3% | -8.9% | -1.1% | 4.6% | 7.8% | 3.4% | 12.4% | 5.1% | 10.0% | 7.2% | 8.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.